Reneo Pharmaceuticals Inc

NASDAQ:RPHM  
2.09
-0.03 (-1.42%)
Earnings Announcements

Reneo Pharmaceuticals Reports Fourth Quarter 2021 Financial Results

Published: 03/23/2022 20:35 GMT
Reneo Pharmaceuticals Inc (RPHM) - Reneo Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business Update.
Q4 Loss per Share $0.43.
Cash Runway Sufficient to Fund Planned Operations Into 2024.
Revenue is expected to be $0 Million
Adjusted EPS is expected to be -$0.58

Next Quarter Revenue Guidance is expected to be $0 Million
Next Quarter EPS Guidance is expected to be -$0.62

More details on our Analysts Page.